Status:

COMPLETED

Non-invasive Transcranial Electrical Stimulation in MS

Lead Sponsor:

University of California, San Francisco

Conditions:

Multiple Sclerosis

Cognitive Impairment

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The goal is to investigate the effects of non-invasive transcranial electrical stimulation on cognition in MS.

Detailed Description

The participants' baseline cognitive function will be assessed with a tablet-based, videogame-like software specifically designed as a medical device to test and train cognitive function for populatio...

Eligibility Criteria

Inclusion

  • age 18-65,
  • diagnosis of MS
  • Expanded Disability Status Scale (EDSS)≤6.5, no paresis of the upper limbs
  • a minimum of 3 months since the last relapse
  • Beck Depression Inventory\<19
  • normal hearing
  • and no changes in MS or symptomatic medications in past 2 months

Exclusion

  • prior brain surgery
  • clips in brain
  • epilepsy or other neurological or non-affective psychiatric disorders
  • pregnancy

Key Trial Info

Start Date :

October 16 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 23 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04466228

Start Date

October 16 2020

End Date

August 23 2022

Last Update

December 4 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCSF Sandler Neurosciences Center

San Francisco, California, United States, 94158